Work

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study

Year: 1995

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/0169-5002(95)00501-3

Authors: Joseph J. Muscato, Constance Cirrincione, Gerald Clamon, Michael C. Perry, George Omura, Irving Berkowitz, Thomas Reid, James E. Herndon, Mark R. Green

Institutions: Hematology Oncology Associates, University of Iowa, University of Missouri, University of Alabama at Birmingham, Walter Reed National Military Medical Center, University of San Diego

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, CANCER AND LEUKEMIA GROUP B

OpenAlex ID: W2000829487

FWCI: 0.708

Cites: 14

Cited by: 10

Related to: 10